Trials / Completed
CompletedNCT01056900
Observation of the Result After Chondron (Autologous Chondrocytes) Treatment
An Investigator-sponsored Trial for Observation of the Result After Chondron (Autologous Chondrocytes) Treatment
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 127 (actual)
- Sponsor
- Cellontech Co., Ltd. · Industry
- Sex
- All
- Age
- 15 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
This investigator-sponsored trial attempts to evaluate the effectiveness of Chondron transplantation by tracking subjects who had the Chondron implantation to observe effectiveness.
Detailed description
Many treatment cases proved that autologous chondrocyte transplantation is a useful treatment method for patients with damaged articular cartilage. This investigator-sponsored trial attempts to evaluate the effectiveness of Chondron(autologous chondrocyte) transplantation by tracking subjects who had the Chondron implantation to observe effectiveness.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Autologous Chondrocyte Implantation | * Test drug: Chondron (more than 12 million chondrocytes in 0.4ml, i.e. 1 vial) * Directions and dosage: Suspend the cells in the vial sufficiently, and implant them in the defective part, making sure that sufficient amounts are injected. |
Timeline
- Start date
- 2008-12-01
- Primary completion
- 2009-08-01
- Completion
- 2009-11-01
- First posted
- 2010-01-26
- Last updated
- 2010-01-26
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT01056900. Inclusion in this directory is not an endorsement.